Electronic Cigarette Use among Survivors of Smoking-Related Cancers in the United States

Akinboro, Oladimeji; Nwabudike, Stanley Madu; Elias, Rawad; Balasire, Oluseyi; Ola, Olatunde; Ostroff, Jamie S.

doi:10.1158/1055-9965.epi-19-0105

Cited by 14 publications

(14 citation statements)

References 22 publications

(33 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 32 - 36 In addition to reinforcing concerns about cigarette smoking of patients with cancer, this study highlights the occurrence of noncigarette tobacco use. Although only 1% of patients with cancer in this study engaged in this behavior, other studies have found that 3%-25% of patients with cancer are current users of electronic cigarettes, 37 , 38 a number that may increase with time, 39 in part because smokers believe that these products aid smoking cessation. 40 Tobacco use is a deeply entrenched behavior that cancer care providers cannot ignore because of fears of upsetting patients or perceptions of inadequate training.…”

Section: Discussioncontrasting

confidence: 55%

Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute–Designated Cancer Center

Burris

Borger

Shelton

et al. 2022

JCO Oncology Practice

View full text Add to dashboard Cite

PURPOSE: Smoking after a cancer diagnosis is linked to cancer-specific and all-cause mortality, among other adverse outcomes. Yet, 10%-20% of US cancer survivors are current smokers. Implementation of evidence-based tobacco treatment in cancer care facilities is widely recommended, yet rarely accomplished. This study focuses on the early outcomes of a population-based tobacco treatment program integrated within an National Cancer Institute–designated cancer center. METHODS AND MATERIALS: The sample consists of 26,365 patients seen at the cancer center during the first 18 months of program implementation. The study is a retrospective chart review of patients' tobacco use and, among current users, patients' treatment referral response. RESULTS: More than 99% of patients were screened for tobacco use. Current (past month) use was observed in 21.05% of patients; cigarettes were the most popular product. Only 17.22% of current users accepted a referral for tobacco treatment; among current users who declined, the majority were not ready to quit (65.84%) or wanted to quit on their own (27.01%). Multiple demographic variables were associated with tobacco use and treatment referral response outcomes. CONCLUSION: Despite cancer diagnosis presenting a teachable moment for tobacco cessation, patients with cancer may not be ready to quit or engage with treatment. Clinically proven strategies to increase motivation, prompt quit attempts, and encourage treatment use should be key components of tobacco treatment delivery to patients with cancer.

show abstract

Section: Discussioncontrasting

confidence: 55%

Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute–Designated Cancer Center

Burris

Borger

Shelton

et al. 2022

JCO Oncology Practice

View full text Add to dashboard Cite

show abstract

“…This study did not ascertain the reason for noncigarette tobacco use, but one could surmise that it is due to the belief these products might aid smoking cessation or be a helpful substitute in places or during times when smoking is prohibited (Popova & Ling, 2013; Shi et al, 2017). Reports of electronic cigarette use in cancer survivors have grown in recent years (Akinboro et al, 2019; Kalkhoran et al, 2018), though research on other products remains rare (see Little et al, 2018 for an exception). Importantly, trial and adoption of electronic cigarettes and the like among cancer survivors who smoke may outpace the rate at which we accumulate empirical evidence of their safety profile and effectiveness for smoking cessation (Kalkhoran & Glantz, 2016; McRobbie et al, 2014).…”

Section: Discussionmentioning

confidence: 99%

A descriptive study of cervical cancer survivors’ persistent smoking behavior and perceived barriers to quitting.

Borger¹,

Puleo²,

Rivera³

et al. 2022

Psychology of Addictive Behaviors

View full text Add to dashboard Cite

Objective: Cervical cancer survivors (CCS) tend to smoke cigarettes at rates much higher than other cancer survivors and women in the general population. However, few studies take a deep dive into the smoking behavior of cervical cancer survivors and none focus on the barriers they experience related to smoking cessation. This study aimed to describe CCS’ tobacco use characteristics, quit attempts, and barriers to quit success. Method: In a concurrent mixed-method design, 50 CCS (94% White nonHispanic) who were diagnosed in the past 5 years and were current smokers at diagnosis provided data via standardized questionnaire and semi-structured interview. Results: More than three-quarters of participants were current smokers at the time of study participation, 25.6% of whom also reported noncigarette tobacco use (e.g., electronic cigarette, cigar, snus). Seventy percent of participants reported making at least one 24 hr quit attempt postdiagnosis, with 61.5% of current smokers preferring to quit without professional advice or counseling and 51.3% preferring to quit without medication assistance. Four themes emerged regarding barriers to smoking cessation: motivation and readiness; confidence and uncertainty; triggers; and social and environmental factors. Conclusions: The rate of smoking in CCS is remarkably high, which may partly be explained by negative attitudes toward and low use of evidence-based treatment as well as multi-level barriers to smoking cessation.

show abstract

“…Our results show that 40% of the participants had ever used other tobacco products, with 10% having used an electronic cigarette in the past 30 days. Other studies have found that 3–25% of patients with cancer are current users of electronic cigarettes [ 48 , 49 ]. Future research could further explore whether smoking cessation programs should consider counselling to encourage the use and success of alternative tobacco products in patients who are unable to quit smoking cigarettes.…”

Section: Discussionmentioning

confidence: 99%

Feasibility of Patient Navigation-Based Smoking Cessation Program in Cancer Patients

Fan

Yingst

Bascom

et al. 2022

IJERPH

View full text Add to dashboard Cite

Continued smoking after a cancer diagnosis is causally associated with increased risks of all-cause and cancer-specific mortality, and of smoking-related second primary cancers. Patient navigation provides individualized assistance to address barriers to smoking cessation treatment and represents a promising bridge to smoking cessation in persons with cancer who smoke cigarettes. We conducted a single-arm interventional cohort study of current smokers identified through prospective health record screening and recruited from Penn State Cancer Institute outpatient clinics. Consented participants received two telephone intervention sessions and gain-framed messaging-based smoking cessation educational materials designed for persons with cancer. The primary study outcome was the feasibility of the patient navigation-based intervention; the secondary outcome was the engagement in smoking cessation treatment at the two-month follow-up. Of 1168 unique screened Cancer Institute patients, 134 (11.5%) were identified as current cigarette smokers. Among 67 patients approached at outpatient clinics, 24 (35.8%) were interested in participating, 12 (17.9%) were enrolled, eight (11.9%) completed the intervention sessions and study assessments, and six engaged in smoking cessation treatment. The participants expressed satisfaction with the intervention sessions (median = 8.5, scale 0–10). The low recruitment rates preclude patient navigation as a feasible method for connecting cancer patients to smoking cessation treatment resources.

show abstract

Electronic Cigarette Use among Survivors of Smoking-Related Cancers in the United States

Cited by 14 publications

References 22 publications

Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute–Designated Cancer Center

Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute–Designated Cancer Center

A descriptive study of cervical cancer survivors’ persistent smoking behavior and perceived barriers to quitting.

Feasibility of Patient Navigation-Based Smoking Cessation Program in Cancer Patients

Contact Info

Product

Resources

About